Precision therapy enasidenib effective in treating deadly form of leukemia

Some patients with relapsed or treatment-resistant acute myeloid leukemia, a form of blood cancer for which there are few treatments, may achieve remission with an experimental targeted therapy, according to early trial data published online today in Blood, a Journal of the American Society of Hematology (ASH).

What feeling does this article give you?
Joy
Disgust
Fear
Anger
Sadness

#hashtags to follow:

American Society of Hematology [+]   

More #news: